Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$31,964,458
+$4,139,014 QoQ
Shares Held
34,453
-9.6% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#78
of 504 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,774,319 across 417 Biotechnology names. ARGX ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
This page
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,964,458 | 34,453 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $27,825,444 | 38,104 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $45,739,269 | 54,390 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $41,062,914 | 55,674 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $30,527,113 | 55,381 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $39,810,613 | 67,263 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $32,417,265 | 52,711 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $24,698,248 | 45,562 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $19,873,007 | 46,212 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $18,749,339 | 47,621 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $16,105,502 | 42,335 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $27,577,983 | 56,095 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,612,347 | 27,230 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $10,005,261 | 26,854 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $9,885,568 | 26,095 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,286,979 | 26,305 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,648,393 | 36,023 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,046,884 | 35,035 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,490,640 | 29,957 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,229,422 | 30,561 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,108,562 | 23,611 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,467,749 | 27,117 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $8,072,181 | 27,448 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $7,184,908 | 27,369 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $5,410,699 | 24,023 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,016,616 | 22,900 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||